nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimetrexate—DHFR—Nucleotide Metabolism—RRM1—adrenal gland cancer	0.226	0.239	CbGpPWpGaD
Trimetrexate—DHFR—Fluoropyrimidine Activity—RRM1—adrenal gland cancer	0.145	0.154	CbGpPWpGaD
Trimetrexate—DHFR—E2F transcription factor network—RRM1—adrenal gland cancer	0.077	0.0815	CbGpPWpGaD
Trimetrexate—DHFR—Retinoblastoma (RB) in Cancer—RRM1—adrenal gland cancer	0.0669	0.0708	CbGpPWpGaD
Trimetrexate—Trimethoprim—ABCB1—adrenal gland cancer	0.0547	1	CrCbGaD
Trimetrexate—DHFR—E2F mediated regulation of DNA replication—RB1—adrenal gland cancer	0.0419	0.0443	CbGpPWpGaD
Trimetrexate—DHFR—Retinoblastoma (RB) in Cancer—TOP2A—adrenal gland cancer	0.0413	0.0437	CbGpPWpGaD
Trimetrexate—DHFR—Mitotic G1-G1/S phases—TOP2A—adrenal gland cancer	0.0291	0.0308	CbGpPWpGaD
Trimetrexate—DHFR—E2F transcription factor network—RB1—adrenal gland cancer	0.0222	0.0235	CbGpPWpGaD
Trimetrexate—DHFR—Fluoropyrimidine Activity—TP53—adrenal gland cancer	0.0205	0.0217	CbGpPWpGaD
Trimetrexate—DHFR—E2F transcription factor network—CDKN2A—adrenal gland cancer	0.0195	0.0206	CbGpPWpGaD
Trimetrexate—DHFR—Retinoblastoma (RB) in Cancer—RB1—adrenal gland cancer	0.0193	0.0204	CbGpPWpGaD
Trimetrexate—DHFR—G1/S Transition—RB1—adrenal gland cancer	0.0161	0.017	CbGpPWpGaD
Trimetrexate—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—adrenal gland cancer	0.0158	0.0168	CbGpPWpGaD
Trimetrexate—DHFR—Mitotic G1-G1/S phases—RB1—adrenal gland cancer	0.0136	0.0143	CbGpPWpGaD
Trimetrexate—DHFR—Mitotic G1-G1/S phases—CDKN2A—adrenal gland cancer	0.0119	0.0126	CbGpPWpGaD
Trimetrexate—DHFR—Folate Metabolism—TP53—adrenal gland cancer	0.0118	0.0124	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—TOP2A—adrenal gland cancer	0.0107	0.0113	CbGpPWpGaD
Trimetrexate—DHFR—Disease—SH3KBP1—adrenal gland cancer	0.0105	0.0111	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—SDHB—adrenal gland cancer	0.0103	0.0109	CbGpPWpGaD
Trimetrexate—DHFR—Disease—ZNRF3—adrenal gland cancer	0.00983	0.0104	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—TOP2A—adrenal gland cancer	0.00954	0.0101	CbGpPWpGaD
Trimetrexate—DHFR—Retinoblastoma (RB) in Cancer—TP53—adrenal gland cancer	0.00943	0.00997	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—PRKACA—adrenal gland cancer	0.00939	0.00994	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—PRKACA—adrenal gland cancer	0.0084	0.00888	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—SDHD—adrenal gland cancer	0.00663	0.00702	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—RRM1—adrenal gland cancer	0.00663	0.00702	CbGpPWpGaD
Trimetrexate—DHFR—Disease—SPRY2—adrenal gland cancer	0.00616	0.00652	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—TERT—adrenal gland cancer	0.00571	0.00605	CbGpPWpGaD
Trimetrexate—DHFR—Disease—MEN1—adrenal gland cancer	0.00564	0.00597	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—RB1—adrenal gland cancer	0.00497	0.00526	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—MED12—adrenal gland cancer	0.00495	0.00523	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—RB1—adrenal gland cancer	0.00445	0.0047	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—CDKN2A—adrenal gland cancer	0.00437	0.00463	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PRKACA—adrenal gland cancer	0.00431	0.00456	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—CDKN2A—adrenal gland cancer	0.00391	0.00414	CbGpPWpGaD
Trimetrexate—DHFR—Disease—CDC42—adrenal gland cancer	0.00365	0.00387	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PRKACA—adrenal gland cancer	0.00361	0.00382	CbGpPWpGaD
Trimetrexate—DHFR—Disease—TERT—adrenal gland cancer	0.00293	0.0031	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—GNAS—adrenal gland cancer	0.00292	0.00309	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ABCB1—adrenal gland cancer	0.00287	0.00304	CbGpPWpGaD
Trimetrexate—DHFR—Disease—BAD—adrenal gland cancer	0.00255	0.0027	CbGpPWpGaD
Trimetrexate—DHFR—Disease—BRAF—adrenal gland cancer	0.00232	0.00246	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—TP53—adrenal gland cancer	0.00218	0.0023	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—POMC—adrenal gland cancer	0.00197	0.00208	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PTGS2—adrenal gland cancer	0.00188	0.00198	CbGpPWpGaD
Trimetrexate—DHFR—Disease—CTNNB1—adrenal gland cancer	0.00168	0.00178	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PTGS2—adrenal gland cancer	0.00157	0.00166	CbGpPWpGaD
Trimetrexate—DHFR—Disease—EGFR—adrenal gland cancer	0.00133	0.00141	CbGpPWpGaD
